<DOC>
	<DOC>NCT01146535</DOC>
	<brief_summary>This study aims to evaluate the safety and effect of interferon-alpha lozenges when used in combination with oseltamivir (Tamiflu) to treat influenza.</brief_summary>
	<brief_title>Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>fever &gt;=38C one or more respiratory symptoms (e.g. cough, rhinorrhea or sore throat) plus one or more constitutional symptoms (e.g. chills, headache, malaise and myalgias)of &lt; 48 hours' duration body weight &gt; 40 kg positive for influenza A (nasal swab rapid test) pregnancy/lactation history of depression or psychiatric disorders history of conditions that could complicate flu infection, such as chronic pulmonary, cardiac, renal, or metabolic disorders use of immunosuppressive therapy HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>interferon-alpha</keyword>
	<keyword>oseltamivir</keyword>
	<keyword>drug therapy, combination</keyword>
	<keyword>influenza</keyword>
	<keyword>therapies, investigational</keyword>
</DOC>